- PRVB Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
-
ETFs
- Insider
- Institutional
- Shorts
-
8-K Filing Data
Provention Bio (PRVB) 8-K22 Nov 21Provention Bio Provides Regulatory Update for Teplizumab At-Risk Type 1 Diabetes Approval PathwayFinancial data
Company Profile